Target Profile
```
Patient's age must be greater than or equal to 18 years.
Patient's gender must be female.
Patient must have active diagnosis of HER2-positive carcinoma of breast.
Patient must have active diagnosis of Estrogen receptor negative neoplasm.
Patient must have active diagnosis of Progesterone receptor negative neoplasm.
Patient must have a health evaluation score of ECOG performance status grade:Prid:Pt:^Patient:Nom:Observed less than or equal to 1.
Patient must not have active diagnosis of Metastasis to brain.
Patient must not have historical diagnosis of Metastasis to brain.
Patient must not have active diagnosis of Leptomeningeal sarcoma.
Patient must not have historical diagnosis of Seizure.
Patient must not have historical diagnosis of Cerebrovascular accident within less than or equal to 12 months.
Patient must not have historical diagnosis of Transient ischemic attack within less than or equal to 12 months.
Patient must not have active diagnosis of Peptic ulcer disease for less than or equal to 3 months.
Patient must not have historical medication with mechanism of action Androgen Synthesis Inhibitors.
Patient must not have historical medication with mechanism of action Androgen Receptor Antagonists.
Patient must not have historical diagnosis of Hepatitis B.
Patient must not have historical diagnosis of Viral hepatitis C.
Patient must not have historical diagnosis of HIV infection.
Patient must not have allergy to substance butylated hydroxyanisole.
Patient must not have allergy to substance butylated hydroxytoluene.
Patient must not have allergy to substance labrasol.
Patient must not have drug allergy to ingredient trastuzumab.
```
